News
PAHC
13.06
+1.71%
0.22
Weekly Report: what happened at PAHC last week (0318-0322)?
Weekly Report · 3d ago
Phibro Stock (PAHC) Rises 7% YTD: Will the Run Continue?
NASDAQ · 6d ago
Here's Why Investors Should Buy Phibro (PAHC) Stock Now
NASDAQ · 03/20 11:55
Weekly Report: what happened at PAHC last week (0311-0315)?
Weekly Report · 03/18 10:52
Weekly Report: what happened at PAHC last week (0304-0308)?
Weekly Report · 03/11 10:50
Phibro (PAHC) Appears Well Poised on Launches, Vaccine Sales
NASDAQ · 03/07 16:02
Weekly Report: what happened at PAHC last week (0226-0301)?
Weekly Report · 03/04 10:53
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
NASDAQ · 03/01 14:40
Weekly Report: what happened at PAHC last week (0219-0223)?
Weekly Report · 02/26 11:03
Weekly Report: what happened at PAHC last week (0212-0216)?
Weekly Report · 02/19 11:05
What Makes Phibro (PAHC) a New Buy Stock
NASDAQ · 02/14 17:00
Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit
Phibro Animal Health Corporation will participate in the Bank of America 2024 Virtual Animal Health Summit. The company will address financial analysts and investors on Thursday, February 29, 2024, at 10:00am ET. The live audio presentation will be available on the company's website.
Barchart · 02/14 15:00
Phibro Animal Health Corp. (PAHC) Passes Through 4% Yield Mark
NASDAQ · 02/13 20:10
Weekly Report: what happened at PAHC last week (0205-0209)?
Weekly Report · 02/12 10:55
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Replimune Group (REPL) and Phibro Animal Health (PAHC)
TipRanks · 02/09 08:40
Phibro (PAHC) Q2 Earnings and Revenues Top, Margins Down
NASDAQ · 02/08 12:29
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), BridgeBio Pharma (BBIO) and Phibro Animal Health (PAHC)
Analysts maintain Buy ratings on 4D Molecular Therapeutics, BridgeBio Pharma and Phibro Animal Health. Goldman Sachs and Bank of America Securities have initiated coverage of the Healthcare sector. The companies have received a lot of coverage today as analysts weigh in on the stocks.
TipRanks · 02/08 11:11
Phibro (PAHC) Reports Q2 Earnings: What Key Metrics Have to Say
NASDAQ · 02/08 01:00
Phibro Animal Health Corp reports results for the quarter ended in December - Earnings Summary
Phibro Animal Health Corp reports quarterly adjusted earnings of 33 cents per share for the quarter ended in December. Revenue rose 2.2% to $249.90 million from a year ago. The company reported quarterly income of $1.3 million. Phibro shares had fallen by 6.6% this quarter.
Reuters · 02/07 23:36
Phibro Animal Health (PAHC) Surpasses Q2 Earnings and Revenue Estimates
NASDAQ · 02/07 23:30
More
Webull provides a variety of real-time PAHC stock news. You can receive the latest news about Phibro Animal through multiple platforms. This information may help you make smarter investment decisions.
About PAHC
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.